These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12242088)

  • 1. Regulation of dihydropyridine-sensitive Ca(2+) channels during naloxone-induced opioid supersensitivity in rats.
    Gullapalli S; Ramarao P
    Eur J Pharmacol; 2002 Sep; 451(3):271-7. PubMed ID: 12242088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of L-type Ca2+ channels in attenuated morphine antinociception in streptozotocin-diabetic rats.
    Gullapalli S; Gurumoorthy K; Kaul CL; Ramarao P
    Eur J Pharmacol; 2002 Jan; 435(2-3):187-94. PubMed ID: 11821025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity.
    Lee SC; Yoburn BC
    Pharmacol Biochem Behav; 2000 Jun; 66(2):347-51. PubMed ID: 10880689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of L-type Ca(2+) channels in pertussis toxin induced antagonism of U50,488H analgesia and hypothermia.
    Gullapalli S; Ramarao P
    Brain Res; 2002 Aug; 946(2):191-7. PubMed ID: 12137921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of dihydropyridine-sensitive Ca++ channels during opioid tolerance and supersensitivity in rats.
    Díaz A; Ruíz F; Flórez J; Pazos A; Hurlé MA
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1538-44. PubMed ID: 7562531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
    Gullapalli S; Ramarao P
    Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system.
    Diaz A; Ruiz F; Flórez J; Hurlé MA; Pazos A
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1545-51. PubMed ID: 7562532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity.
    Hurlé MA
    J Neurochem; 2001 Apr; 77(2):486-92. PubMed ID: 11299311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
    J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system.
    Díaz A; Flórez J; Pazos A; Hurlé MA
    Pain; 2000 Jun; 86(3):227-235. PubMed ID: 10812252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic mapping of mu-opioid receptors during opiate tolerance and supersensitivity in the rat central nervous system.
    Díaz A; Pazos A; Flórez J; Hurlé MA
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):101-9. PubMed ID: 10961371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine-induced analgesia in rats withdrawn from concurrent nimodipine and morphine treatment.
    Zharkovsky A; Katajamäki J; Seppälä T; Ahtee L
    Pain; 1999 Feb; 79(2-3):217-22. PubMed ID: 10068167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
    Yoburn BC; Sierra V; Lutfy K
    Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of omega-conotoxin GVIA, nimodipine, calmidazolium and KN-62 injected intrathecally on the antinociception induced by beta-endorphin, morphine and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin administered intracerebroventricularly in the mouse.
    Suh HW; Song DK; Choi SR; Huh SO; Kim YH
    J Pharmacol Exp Ther; 1997 Aug; 282(2):961-6. PubMed ID: 9262364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine.
    Yamada S; Uchida S; Ohkura T; Kimura R; Yamaguchi M; Suzuki M; Yamamoto M
    J Pharmacol Exp Ther; 1996 May; 277(2):721-7. PubMed ID: 8627551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of various Ca2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat.
    Michaluk J; Karolewicz B; Antkiewicz-Michaluk L; Vetulani J
    Eur J Pharmacol; 1998 Jul; 352(2-3):189-97. PubMed ID: 9716354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine withdrawal in cortical slices: suppression by Ca2+-channel inhibitors of abstinence-induced [3H]-noradrenaline release.
    Pellegrini-Giampietro DE; Bacciottini L; Carlà V; Moroni F
    Br J Pharmacol; 1988 Mar; 93(3):535-40. PubMed ID: 2453241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.
    Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.